Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

S 396: Relates to investigating critical prescription drug pricing

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

S 396 is a bill introduced in the New York Senate on January 8, 2025. According to its official title, it concerns: Relates to investigating critical prescription drug pricing. Primary sponsor: Zellnor Myrie (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Zellnor MyriePrimary sponsorDemocraticSenate20

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO INSURANCE
  2. REFERRED TO INSURANCE

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source